Page 4 of 19 · 454 questions tagged vendor-vetting.
Setup, so nobody has to ask: GL Biochem · survodutide. Somebody stated this to me confidently and I would like to check it before repeating it. I would accept a…
The particulars: SWB · retatrutide. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence exists and…
The lane and the lead time matter as much as the material for what I am doing. I want a method I can write down and repeat, not a rule of thumb. I would rather…
What I am working with: BCH · mazdutide. This is not behaving the way I expected and I want to understand the discrepancy before I act on it. I have photographed the…
The particulars: KP · orforglipron. I have a result I cannot explain, and I would rather diagnose it than guess. I have checked the obvious explanations and…
What I have: QYB · ecnoglutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would like that…
Numbers first: 96.4% · dulaglutide · MKM. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…
Setup, so nobody has to ask: ecnoglutide · method section. I would like to know the limits of what can be inferred from this. What I am trying to avoid is…
The particulars: ecnoglutide · date of analysis. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
Concretely: QST · liraglutide. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know whether this is…
I am comparing three suppliers on documentation rather than on price. Everything I have found on this is either a forum aside or a product page, neither of which I…
Setup, so nobody has to ask: chromatogram · SSA. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
Conditions: QST · Shanghai Wibson Biotechnology. I would like the axes of comparison first and the recommendation second. I have tried the first option and it works;…
Stated plainly: KP · Shanghai ERP Biotechnology. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
The case in front of me: CPC · tirzepatide. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know whether…
Stated plainly: Homopeptide · Zhuhai Kerui Biotechnology. I would like the axes of comparison first and the recommendation second. I have tried the first option and…
I have certificates from two lots and an independent result on one of them. I can find plenty of assertions about this and almost no reasoning, which is usually a…
The lot number on the vial matches the certificate, which at least rules out the easy problem. I keep seeing this stated as a fact with no explanation attached, and…
Setup, so nobody has to ask: retatrutide · sampling plan. I have read the primary source rather than the summary, which has left me with more questions. I understand…
Setup, so nobody has to ask: WXT · a GLP-1 receptor agonist. This is asserted often enough that I assumed it was established, and then I went looking for the source.…
The lot number on the vial matches the certificate, which at least rules out the easy problem. Everything I have found on this is either a forum aside or a product…
I have both a purity figure and a content figure, which is why the discrepancy is visible. I would like the mechanism, because I want to be able to reason about the…
Setup, so nobody has to ask: semaglutide · method section. I would like to know the limits of what can be inferred from this. What I am trying to avoid is…
Conditions: 97.1% · liraglutide · BCH. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the…